Omega Fund V Gp, L.p. - Net Worth and Insider Trading
Omega Fund V Gp, L.p. Net Worth
The estimated net worth of Omega Fund V Gp, L.p. is at least $252 Million dollars as of 2024-04-28. Omega Fund V Gp, L.p. is the 10% Owner of Nuvation Bio Inc and owns about 23,457,340 shares of Nuvation Bio Inc (NUVB) stock worth over $127 Million. Omega Fund V Gp, L.p. is the Director of Morphic Holding Inc and owns about 2,086,071 shares of Morphic Holding Inc (MORF) stock worth over $59 Million. Omega Fund V Gp, L.p. is also the 10% Owner of Nuvation Bio Inc and owns about 20,457,340 shares of Nuvation Bio Inc (NUVB) stock worth over $55 Million. Besides these, Omega Fund V Gp, L.p. also holds Gossamer Bio Inc (GOSS) , Kronos Bio Inc (KRON) , Trevi Therapeutics Inc (TRVI) . Details can be seen in Omega Fund V Gp, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Omega Fund V Gp, L.p. has not made any transactions after 2022-04-05 and currently still holds the listed stock(s).
Transaction Summary of Omega Fund V Gp, L.p.
Omega Fund V Gp, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Omega Fund V Gp, L.p. owns 7 companies in total, including Kronos Bio Inc (KRON) , Gossamer Bio Inc (GOSS) , and Morphic Holding Inc (MORF) among others .
Click here to see the complete history of Omega Fund V Gp, L.p.’s form 4 insider trades.
Insider Ownership Summary of Omega Fund V Gp, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KRON | Kronos Bio Inc | 2020-10-14 | 10 percent owner |
| GOSS | Gossamer Bio Inc | 2019-09-20 | 10 percent owner |
| MORF | Morphic Holding Inc | 2021-04-28 | director |
| TRVI | Trevi Therapeutics Inc | 2019-05-09 | 10 percent owner |
| IMUX | Immunic Inc | 2019-04-12 | 10 percent owner |
| TBIO | Translate Bio Inc | 2018-07-02 | 10 percent owner |
| NUVB | Nuvation Bio Inc | 2022-04-05 | 10 percent owner |
Omega Fund V Gp, L.p. Latest Holdings Summary
Omega Fund V Gp, L.p. currently owns a total of 6 stocks. Among these stocks, Omega Fund V Gp, L.p. owns 23,457,340 shares of Nuvation Bio Inc (NUVB) as of December 7, 2021, with a value of $127 Million and a weighting of 50.59%. Omega Fund V Gp, L.p. owns 2,086,071 shares of Morphic Holding Inc (MORF) as of April 28, 2021, with a value of $59 Million and a weighting of 23.23%. Omega Fund V Gp, L.p. also owns 20,457,340 shares of Nuvation Bio Inc (NUVB) as of April 5, 2022, with a value of $55 Million and a weighting of 21.75%. The other 3 stocks Gossamer Bio Inc (GOSS) , Kronos Bio Inc (KRON) , Trevi Therapeutics Inc (TRVI) have a combined weighting of 4.43% among all his current holdings.
Latest Holdings of Omega Fund V Gp, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NUVB | Nuvation Bio Inc | 2021-12-07 | 23,457,340 | 5.44 | 127,490,643 |
| MORF | Morphic Holding Inc | 2021-04-28 | 2,086,071 | 28.07 | 58,556,013 |
| NUVB | Nuvation Bio Inc | 2022-04-05 | 20,457,340 | 2.68 | 54,825,671 |
| GOSS | Gossamer Bio Inc | 2019-09-20 | 6,553,416 | 0.67 | 4,377,682 |
| KRON | Kronos Bio Inc | 2020-10-14 | 3,818,283 | 1.00 | 3,818,283 |
| TRVI | Trevi Therapeutics Inc | 2019-05-09 | 1,063,408 | 2.78 | 2,956,274 |
Holding Weightings of Omega Fund V Gp, L.p.
Omega Fund V Gp, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Omega Fund V Gp, L.p. has made a total of 4 transactions in Nuvation Bio Inc (NUVB) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Nuvation Bio Inc is the sale of 1,400,000 shares on December 7, 2021, which brought Omega Fund V Gp, L.p. around $14 Million.
According to the SEC Form 4 filings, Omega Fund V Gp, L.p. has made a total of 39 transactions in Morphic Holding Inc (MORF) over the past 5 years, including 1 buys and 38 sells. The most-recent trade in Morphic Holding Inc is the sale of 10,704 shares on April 28, 2021, which brought Omega Fund V Gp, L.p. around $593,216.
According to the SEC Form 4 filings, Omega Fund V Gp, L.p. has made a total of 1 transactions in Nuvation Bio Inc (NUVB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Nuvation Bio Inc is the sale of 2,500,000 shares on April 5, 2022, which brought Omega Fund V Gp, L.p. around $14 Million.
More details on Omega Fund V Gp, L.p.'s insider transactions can be found in the Insider Trading History of Omega Fund V Gp, L.p. table.Insider Trading History of Omega Fund V Gp, L.p.
- 1
Omega Fund V Gp, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Omega Fund V Gp, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Omega Fund V Gp, L.p. is -19.89%. GuruFocus also compares Omega Fund V Gp, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Omega Fund V Gp, L.p. within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Omega Fund V Gp, L.p.'s insider trading performs compared to the benchmark.
Performance of Omega Fund V Gp, L.p.
Average Return
-34.36%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.39 | -19.89 | -37.24 | -34.36 | -20.12 | -35.38 |
| Relative Return to S&P 500(%) | -0.44 | -23.11 | -48.9 | -45.82 | -34.61 | -44.68 |
Omega Fund V Gp, L.p. Ownership Network
Ownership Network List of Omega Fund V Gp, L.p.
Ownership Network Relation of Omega Fund V Gp, L.p.
Omega Fund V Gp, L.p. Owned Company Details
What does Kronos Bio Inc do?
Who are the key executives at Kronos Bio Inc?
Omega Fund V Gp, L.p. is the 10 percent owner of Kronos Bio Inc. Other key executives at Kronos Bio Inc include COO & General Counsel Barbara Kosacz , Chief Scientific Officer Christopher Dinsmore , and Chief Medical Officer & VP Jorge Dimartino .
Kronos Bio Inc (KRON) Insider Trades Summary
Over the past 18 months, Omega Fund V Gp, L.p. made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net sale of 69,004 shares made by Jorge Dimartino , a net sale of 39,461 shares made by Christopher Dinsmore , and a net sale of 18,643 shares made by Yasir B. Al-wakeel .
In summary, during the past 3 months, insiders sold 31,509 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 31,509 shares. During the past 18 months, 169,293 shares of Kronos Bio Inc (KRON) were sold and 1,731,056 shares were bought by its insiders, resulting in a net purchase of 1,561,763 shares.
Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kronos Bio Inc Insider Transactions
Omega Fund V Gp, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Omega Fund V Gp, L.p.. You might contact Omega Fund V Gp, L.p. via mailing address: 888 Boylston St., Suite 1111, Boston Ma 02199.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
